Early implementation of West Synchrony S1 platform aims to accelerate biologics and vaccine development while reducing manufacturing risk for biopharma partners
Precision medicine company advances Raman spectroscopy-based therapeutic drug monitoring platform for rapid, patient-specific dosing solutions
Acquisition of medical equipment distributor aims to strengthen European commercial operations and optimise distribution costs
The move puts a spotlight on one of psychiatry’s most persistent clinical challenges: misdiagnosis and delay
Both join the leading CRDMO’s executive committee to drive global people strategy and commercial expansion
Patients receiving ELREXFIO largely remained free from disease progression during the interim analysis
The agreement could rise to $900 million if key commercial milestones are met
The company receives approval for blood-based test enabling objective differentiation of schizophrenia and bipolar disorder
Patients, doctors, and caregivers come together to promote awareness, early intervention, and pain-free living
The lens received U.S. Food and Drug Administration (FDA) market authorization via the De Novo pathway in late 2025
Subscribe To Our Newsletter & Stay Updated
